William Duke

Chief Executive Officer at INVIVYD, INC.

Net worth: 122 797 $ as of 2026-05-30

53 year

70 connections

Health Technology

Consumer Services

Communications

Profile

William E.
Duke is Chief Executive, Financial & Accounting Officer at Invivyd, Inc. since 2024.
Former roles include Chief Financial Officer at Apexigen, Inc. from 2022 to 2023; Chief Financial & Accounting Officer at Kaleido Biosciences, Inc. from 2019 to 2022; Chief Financial Officer, Secretary & Treasurer at Pulmatrix, Inc. from 2015 to 2019; Chief Financial Officer & Head-Investor Relations at Valeritas, Inc. in 2015; Senior Director-Finance at Genzyme Corp.
from 2010 to 2011; Director-Finance & Accounting at Haemonetics Corp.
from 2008 to 2010; Chief Financial Officer at g8wave Holdings, Inc. from 2007 to 2008; and Chief Financial Officer at OTF Group, Inc. Education includes an MBA from Bentley University and undergraduate studies at Stonehill College, Inc.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
INVIVYD, INC. 0.04%	2026-03-19	107,717 ( 0.04% )	122 797 $	2026-05-30

William Duke active positions

Companies	Position	Start
INVIVYD, INC.	Chief Executive Officer	2024-05-29

All active positions of William Duke

Former positions of William Duke

Companies	Position	End
APEXIGEN, INC.	Director of Finance/CFO	2023-08-22
KALEIDO BIOSCIENCES, INC.	Director of Finance/CFO	2022-04-07
PULMATRIX, INC.	Director of Finance/CFO	2019-11-21
VALERITAS INC	Director of Finance/CFO	2015-05-31
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Director of Finance/CFO	-

See the detail of William Duke's experience

Training of William Duke

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of William Duke's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	11
Haemonetics Corp. Haemonetics Corp. Medical SpecialtiesHealth Technology Designs, manufactures, markets and services blood processing systems	Health Technology
Genzyme Corp. Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology	Health Technology
g8wave Holdings, Inc. g8wave Holdings, Inc. Specialty TelecommunicationsCommunications Provides planning, creating and executing effective mobile marketing campaigns and content distribution strategies	Communications
Bentley University Bentley University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Stonehill College, Inc. Stonehill College, Inc. Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
OTF Group, Inc. OTF Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services	Commercial Services
Valeritas, Inc. Valeritas, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug delivery solutions for the treatment of diabetes	Health Technology
Pulmatrix, Inc. Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease	Health Technology
Kaleido Biosciences, Inc. Kaleido Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome	Health Technology
Invivyd, Inc. Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases	Health Technology
Apexigen, Inc. Apexigen, Inc. BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancer	Health Technology